SciSight Ecosystem
WoS SCIE Q3Scopus Q2SCImago #4,523CAS 3区Gold OA

Hereditary Cancer in Clinical Practice

Abbreviation (ISO):HERED CANCER CLIN PR
Country: Poland•WoS SCIE Quartile: Q3•Scopus SJR: 1.049•SCImago Rank: #4,523•Identifier (ISSN):1731-2302(Print)/1897-4287(Online)•Articles / Year: 45•Estimated Publication Fee (APC): $3,117 USD
Clarivate IF (2026)Q3
2.8
↑ +0.4

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
21

21 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
45articles/year
100% Gold OA•74.29% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.8)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.8)
🔵 Computed
20251.50đ
WoS Q3(IF: 2.4)
🔵 Computed
20241.50đ
WoS Q3(IF: 2)
🔵 Computed
20231.50đ
WoS Q3(IF: 1.7)
🔵 Computed
20221.50đ
WoS Q3(IF: 2.164)
🔵 Computed
20211.50đ
WoS Q3(IF: 2.857)
🔵 Computed
20201.50đ
WoS Q3(IF: 2.237)
🔵 Computed
20191.50đ
WoS Q3(IF: 1.78)
🔵 Computed
20181.50đ
WoS Q3(IF: 2.027)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a discussion forum for the development appropriate healthcare strategies. Cancer genetics encompasses a wide variety of disciplines and knowledge in the field is rapidly growing, especially as the amount of information linking genetic differences to inherited cancer predispositions continues expanding. With the increased knowledge of genetic variability and how this relates to cancer risk there is a growing demand not only to disseminate this information into clinical practice but also to enable competent debate concerning how such information is managed and what it implies for patient care. Topics covered by the journal include but are not limited to: Original research articles on any aspect of inherited predispositions to cancer. Reviews of inherited cancer predispositions. Application of molecular and cytogenetic analysis to clinical decision making. Clinical aspects of the management of hereditary cancers. Genetic counselling issues associated with cancer genetics. The role of registries in improving health care of patients with an inherited predisposition to cancer.

Topics Covered (Recognized by AI)
Biology99.1%Medicine98.9%Genetics97.8%Internal medicine91%Cancer83.6%Chemistry82.5%Biochemistry81.2%Gene77%Oncology48.3%Pathology46.3%Mutation43.7%Breast cancer36.1%Colorectal cancer34.6%Germline mutation33.4%Surgery32.8%DNA28.8%Sociology25.3%DNA repair25%Radiology25%Human genetics23.6%Gynecology22.5%DNA mismatch repair21.4%Demography21%Ovarian cancer20.2%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,523Scopus Q2SCImago Profile
Scopus Coverage:2003-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
1.049

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
36

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.75

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,117 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations247
3-Year Documents91
Citable Documents86

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate61.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Genetics (clinical)Q2
OncologyQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
BioMed Central
Publication Language
English
Frequency
Quarterly
Founding Year
2003
Editorial Address
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
Indexing & Databases
SCIEScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
179/333Q3
ONCOLOGY
JCISCIE
235/333Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—173
20252.42842
2024227139
20231.728194
20222.16438407
20212.85749403
20202.23725300
20191.7833648
20182.02717273
2017—22476
2016—20400
2015—51481
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Hereditary Cancer in Clinical Practice

WoS Q3
1234201820192020202120222023202420252.40
Annual Impact Factor Metric
2025:2.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b18ae2c7-2ddd-4f99-8fae-9c84110ac136
Database Updated: 2026-10-01